Functional microclinisy pre -clinical research project experimental results launch conference was held at the Kangting Group

Zhongxin Jingwei, August 29th. On August 26th, the Kangting Institute of Biomedicine's Institute of Biomedicine's "Mergersal Source Function Functional Flow of Micro Boam Boil in the Anthropomy of Anti -Human Long Animal Disease Model and Kang Ting Group The Cooperation Signing Ceremony of the Integrated Research Center of "Production, Studies, Research, and Medical" was held.

Pang Tieqiang, deputy head of the Xiqing District Government of Tianjin, Huang Yalou, Secretary of the Party Committee of Tianjin International Biomedical Joint Research Institute, Li Tong, Secretary of the Party Committee of the Third Central Hospital of Tianjin, and the leaders and guests of the Minister of Scientific Research Department of Nankai University. Mr. Liu Xiaobing, Ms. Yang Qi, President of the Group, and Mr. Li Yuming, Dean of Kanghui Hospital, attended the event.

It is understood that the release of this results is presented in the form of video. By explaining the research background of the project, the participants further realized that the functional microcapsule bubbles of mesenchymal stem cells have good effects. As a natural carrier of load drugs and exogenous nucleic acids, it has broad application prospects.

Starting from the actual situation, purulent hemorrhoids, as a category of critical illness due to the disorders of individual immune reactions and caused a high -level inflammatory response, lead to death of about 6 million diseases each year. At present, the treatment of purulentmia is lacking.

To this end, the Kangting Institute of Biomedicine focuses on exploring the possibility of treating various types of functional microcapsules for the treatment of diseases such as purulent and deh. Studies have found that in cell and small animal purulent hemostatic models, the expression level of inflammatory factors such as IL-6, IL-8, TNF-α has increased significantly. After 24 hours of microcopae treatment, the expression of the above inflammation factor is raised up. Get inhibitory. On this basis, in order to further promote the transformation of the clinical application of scientific research results, researchers have explored the treatment effect of inter -germaneous stem cell source functional microcapsules on non -human long animals.

Crab monkeys are divided into blank control groups, purulent leather model groups, low/high -dose inductive mesenchymal stem cell source function microcapped foamed treatment group, induced mesenchymal stem cell source functional microcapsule pre -protection group, After the general mesenchymal stem cell source functional microcapped foam treatment group and the experiments were launched, a number of related physiological indicators related to blood, liver/kidney function, inflammatory factor level, etc. were detected. The health level of functional microcapsule treatment or prevention group has improved significantly. For example, key indicators such as inflammation factor IL-6, TNF-α, ultravisistocratic C-reactive protein, D-di body and other key indicators detected significantly increased in the purulent hemiamine model group; After 6 hours of administration, the test results showed that the IL-6 level was reduced by 23.3%, and the TNF-α level decreased by 14.8%; after 24 hours of administration, the level %, All showing a significant decline.

In his speech, Huang Yalou proposed that the United Research Institute, as a large -scale biomedical science and technology complex co -built by the Ministry of Science and Technology and the Tianjin People's Government, has carried the technology research and development, results transformation, corporate incubation, and talent citations. Important mission. Since its establishment, the joint research institute has established a number of technical support platforms such as early discovery, preclinical research, and clinical trials covering drugs, and has received special support for major national new drug creation. In the future, the joint research institute will further integrate and coordinate the advantages of all parties, fully implement the positioning of the joint research institute's duties, and effectively promote the clinical transformation of many scientific research projects of the Kangting Group.

Achievement release

On the same day, Gao Wenqing, deputy director of the key laboratory of severe illness support in Tianjin, and Yan Lingzhou, head of the Division of Tianjin International Biomedicine Joint Research Institute, successively with the "clinical significance of purulent venom and the advantages of clinical trials of all parties in clinical trials" And the theme of the "The Institute of United Research Institute in the Development of the Service Industry" as a special report on the theme, which jointly explained the development trend of the current clinical diagnosis and treatment and the biomedical industry, and emphasized that "production, learning, research, medicine" has more The importance and inevitability of coordinated development.

Experts and scholars from the Group and major universities also focus on the core content of this event, and conduct exchanges and discussions from various levels such as technological innovation, clinical application, and market prospects. Essence Under the witness of leaders and guests present, representatives of Kang Ting Group, Joint Research Institute, Nankai University, and Sanzhong Hospital jointly signed a joint intention of cooperation between the "Industry, Studies, Research, and Medical" integrated research center to strive to lead biomedicine The industry realizes leapfrog innovation and development.

Sign cooperation and co -construction intention

Chairman Liu Xiaobing said that the Kang Ting Group will adhere to the mission of "focusing on health, care for life, and benefiting human beings", and actively promote comprehensive innovation with scientific and technological innovation as its core. In the future, the Group will further establish a coordinated innovation mechanism, coordinate the resources of cooperative institutions, jointly carry out technical research, product development, results transformation, and project incubation, and continuously improve the group's big health industry territory, and strive to bring the gospel to more groups of health problems to bring the gospel Essence (Zhongxin Jingwei APP)

- END -